Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor

Details for Australian Patent Application No. 2007311052 (hide)

Owner University of North Carolina at Chapel Hill Biogen Idec MA Inc.

Inventors Ting, Jenny P-Y.; Browning, Jeffrey

Agent Cullen & Co

Pub. Number AU-A-2007311052

PCT Pub. Number WO2008/049053

Priority 60/862,343 20.10.06 US

Filing date 18 October 2007

Wipo publication date 24 April 2008

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61M 3/00 (2006.01) Syringes

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

21 May 2009 PCT application entered the National Phase

  PCT publication WO2008/049053 Priority application(s): WO2008/049053

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007311054-Mux BOP database mirroring

2007311049-Buoyant track amphibious transporter